RIPK4 promotes oxidative stress and ferroptotic death through the downregulation of ACSM1.

Jing Zhang, Yuehan Wei, Yangbo Yue, Huike Jiao, Yan Wu, Wan Fu, Keng-Mean Lin, Christopher Lu, Shan Mou, Qing Zhong
Author Information
  1. Jing Zhang: Department of Pathophysiology, Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of Education, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China. ORCID
  2. Yuehan Wei: Department of Nephrology, Molecular Cell Lab for Kidney Disease, Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China.
  3. Yangbo Yue: Department of Pathophysiology, Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of Education, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
  4. Huike Jiao: Department of Pathophysiology, Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of Education, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China. ORCID
  5. Yan Wu: Department of Pathophysiology, Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of Education, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
  6. Wan Fu: Department of Pathophysiology, Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of Education, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
  7. Keng-Mean Lin: Division of Nephrology, Department of Internal Medicine and the Graduate Program in Immunology, University of Texas Southwestern Medical Center, Dallas, TX 75390-8856.
  8. Christopher Lu: Division of Nephrology, Department of Internal Medicine and the Graduate Program in Immunology, University of Texas Southwestern Medical Center, Dallas, TX 75390-8856.
  9. Shan Mou: Department of Nephrology, Molecular Cell Lab for Kidney Disease, Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China.
  10. Qing Zhong: Department of Pathophysiology, Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of Education, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China. ORCID

Abstract

One of the most critical axes for cell fate determination is how cells respond to excessive reactive oxygen species (ROS)-oxidative stress. Extensive lipid peroxidation commits cells to death via a distinct cell death paradigm termed ferroptosis. However, the molecular mechanism regulating cellular fates to distinct ROS remains incompletely understood. Through siRNA against human receptor-interacting protein kinase (RIPK) family members, we found that RIPK4 is crucial for oxidative stress and ferroptotic death. Upon ROS induction, RIPK4 is rapidly activated, and the kinase activity of RIPK4 is indispensable to induce cell death. Specific ablation of RIPK4 in kidney proximal tubules protects mice from acute kidney injury induced by cisplatin and renal ischemia/reperfusion. RNA sequencing revealed the dramatically decreased expression of acyl-CoA synthetase medium-chain (ACSM) family members induced by cisplatin treatment which is compromised in RIPK4-deficient mice. Among these ACSM family members, suppression of ACSM1 strongly augments oxidative stress and ferroptotic cell death with induced expression of ACS long-chain family member 4, an important component for ferroptosis execution. Our lipidome analysis revealed that overexpression of ACSM1 leads to the accumulation of monounsaturated fatty acids, attenuation of polyunsaturated fatty acid (PUFAs) production, and thereby cellular resistance to ferroptosis. Hence, knockdown of ACSM1 resensitizes RIPK4 KO cells to oxidative stress and ferroptotic death. In conclusion, RIPK4 is a key player involved in oxidative stress and ferroptotic death, which is potentially important for a broad spectrum of human pathologies. The link between the RIPK4-ASCM1 axis to PUFAs and ferroptosis reveals a unique mechanism to oxidative stress-induced necrosis and ferroptosis.

Keywords

References

  1. Cancer Cell. 2018 Jul 9;34(1):21-43 [PMID: 29731393]
  2. Prog Lipid Res. 1997 Mar;36(1):55-83 [PMID: 9373621]
  3. Cell Mol Immunol. 2020 Apr;17(4):356-368 [PMID: 31076724]
  4. Curr Biol. 2014 May 19;24(10):R453-62 [PMID: 24845678]
  5. Annu Rev Immunol. 1997;15:351-69 [PMID: 9143692]
  6. Neuron. 2004 Nov 18;44(4):601-7 [PMID: 15541309]
  7. J Biol Chem. 2001 Jun 15;276(24):21737-44 [PMID: 11278382]
  8. J Am Soc Nephrol. 2015 Nov;26(11):2647-58 [PMID: 25788533]
  9. Cell. 2017 Oct 5;171(2):273-285 [PMID: 28985560]
  10. Nat Rev Drug Discov. 2020 Aug;19(8):553-571 [PMID: 32669658]
  11. Cell Metab. 2024 Apr 2;36(4):762-777.e9 [PMID: 38309267]
  12. Curr Biol. 2002 Aug 20;12(16):1424-8 [PMID: 12194825]
  13. Expert Opin Drug Metab Toxicol. 2016 Oct;12(10):1169-79 [PMID: 27351777]
  14. Am J Cancer Res. 2022 Apr 15;12(4):1824-1842 [PMID: 35530294]
  15. Cell Chem Biol. 2020 Apr 16;27(4):365-375 [PMID: 32294465]
  16. Am J Physiol Renal Physiol. 2020 Oct 1;319(4):F603-F611 [PMID: 32830538]
  17. Proc Natl Acad Sci U S A. 2014 Nov 25;111(47):16836-41 [PMID: 25385600]
  18. Nature. 2019 Oct;574(7777):249-253 [PMID: 31578523]
  19. J Biol Chem. 2000 Nov 17;275(46):36350-7 [PMID: 10948194]
  20. Proc Natl Acad Sci U S A. 2024 Oct;121(40):e2410628121 [PMID: 39316049]
  21. Nature. 2002 Mar 14;416(6877):194-9 [PMID: 11894098]
  22. Nat Chem Biol. 2017 Jan;13(1):91-98 [PMID: 27842070]
  23. Nat Rev Mol Cell Biol. 2021 Apr;22(4):266-282 [PMID: 33495651]
  24. Cell. 2009 Jun 12;137(6):1100-11 [PMID: 19524512]
  25. Nat Immunol. 2000 Dec;1(6):489-95 [PMID: 11101870]
  26. Annu Rev Pharmacol Toxicol. 2013;53:401-26 [PMID: 23294312]
  27. Cell Mol Immunol. 2010 Jul;7(4):243-9 [PMID: 20383176]
  28. Annu Rev Pathol. 2017 Jan 24;12:103-130 [PMID: 27959630]
  29. Proc Natl Acad Sci U S A. 2020 Dec 8;117(49):31189-31197 [PMID: 33229547]
  30. Cell. 2012 Jan 20;148(1-2):213-27 [PMID: 22265413]
  31. Nat Chem Biol. 2017 Jan;13(1):81-90 [PMID: 27842066]
  32. Cell. 2009 Jun 12;137(6):1112-23 [PMID: 19524513]
  33. Structure. 2018 May 1;26(5):767-777.e5 [PMID: 29706531]
  34. Science. 2009 Jul 17;325(5938):332-6 [PMID: 19498109]
  35. Am J Hum Genet. 2012 Jan 13;90(1):76-85 [PMID: 22197489]
  36. Cell. 2024 Jan 18;187(2):235-256 [PMID: 38242081]
  37. Nat Chem Biol. 2008 May;4(5):313-21 [PMID: 18408713]
  38. Cell Chem Biol. 2019 Mar 21;26(3):309-311 [PMID: 30901556]

Grants

  1. M-1040/MOST | National Natural Science Foundation of China (NSFC)
  2. 91957204/MOST | National Natural Science Foundation of China (NSFC)
  3. P30 DK079328/NIDDK NIH HHS
  4. 2023YFA0914900/Ministry of Science and Technology of the People's Republic of China (MOST)
  5. 32370794/MOST | National Natural Science Foundation of China (NSFC)
  6. 92254307/MOST | National Natural Science Foundation of China (NSFC)
  7. 91754205/MOST | National Natural Science Foundation of China (NSFC)
  8. 32070734/MOST | National Natural Science Foundation of China (NSFC)

MeSH Term

Animals
Oxidative Stress
Ferroptosis
Mice
Coenzyme A Ligases
Humans
Reactive Oxygen Species
Cisplatin
Down-Regulation
Mice, Knockout
Acute Kidney Injury
Protein Serine-Threonine Kinases
Reperfusion Injury
Cell Death
Receptor-Interacting Protein Serine-Threonine Kinases
Long-Chain-Fatty-Acid-CoA Ligase

Chemicals

Coenzyme A Ligases
Reactive Oxygen Species
Cisplatin
Protein Serine-Threonine Kinases
Acsl4 protein, mouse
Receptor-Interacting Protein Serine-Threonine Kinases
Long-Chain-Fatty-Acid-CoA Ligase

Word Cloud

Created with Highcharts 10.0.0deathstressRIPK4oxidativeferroptosisfamilyferroptoticcellACSM1cellsROSkinasememberskidneyinduceddistinctmechanismcellularhumanproteinmiceacuteinjurycisplatinrevealedexpressionacyl-CoAsynthetasemedium-chainACSMimportantfattyPUFAsOnecriticalaxesfatedeterminationrespondexcessivereactiveoxygenspecies-oxidativeExtensivelipidperoxidationcommitsviaparadigmtermedHowevermolecularregulatingfatesremainsincompletelyunderstoodsiRNAreceptor-interactingRIPKfoundcrucialUponinductionrapidlyactivatedactivityindispensableinduceSpecificablationproximaltubulesprotectsrenalischemia/reperfusionRNAsequencingdramaticallydecreasedtreatmentcompromisedRIPK4-deficientAmongsuppressionstronglyaugmentsACSlong-chainmember4componentexecutionlipidomeanalysisoverexpressionleadsaccumulationmonounsaturatedacidsattenuationpolyunsaturatedacidproductiontherebyresistanceHenceknockdownresensitizesKOconclusionkeyplayerinvolvedpotentiallybroadspectrumpathologieslinkRIPK4-ASCM1axisrevealsuniquestress-inducednecrosispromotesdownregulationreceptorinteracting

Similar Articles

Cited By